Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with …

AR Saniabadi, H Hanai, K Takeuchi… - Therapeutic …, 2003 - Wiley Online Library
Apheresis has been recognized both economically and therapeuticallyas a novel approach
for the treatment of inflammatory diseases, and certain others, which respond poorly to drug …

The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review

H Hanai, Y Takeda, M Eberhardson… - Clinical & …, 2011 - academic.oup.com
Patients with active inflammatory bowel disease (IBD) have elevated and activated myeloid
leucocytes which infiltrate the colonic mucosa in vast numbers. Myeloid leucocytes such as …

Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study

T Shimoyama, K Sawada, N Hiwatashi… - Journal of Clinical …, 2001 - Wiley Online Library
Active ulcerative colitis (UC) is characterized by activation and infiltration of granulocytes
and monocytes/macrophages into the colonic mucosa. The infiltrated leukocytes can cause …

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi, T Iida… - Clinical …, 2003 - Elsevier
Background & Aims: Active ulcerative colitis (UC) is characterized by infiltration of activated
granulocytes and monocytes/macrophages (GM) within the large bowel mucosa. GM are …

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis

N Kashiwagi, K Sugimura, H Koiwai… - Digestive diseases and …, 2002 - Springer
Our aim was to understand the mechanism of immunological changes associated with the
use of an adsorptive-type extracorporeal device (Adacolumn) that has been developed for …

Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled …

Y Suzuki, N Yoshimura, AR Saniabadi… - Digestive diseases and …, 2004 - Springer
Corticosteroid therapy of ulcerative colitis (UC) is associated with frequent adverse side
effects and poor quality of life. Recently, adsorptive granulocyte and monocyte/macrophage …

Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis

H Hanai, F Watanabe, M Yamada, Y Sato, K Takeuchi… - Digestion, 1945 - karger.com
Background/Aim: Active ulcerative colitis (UC) is often associated with increased peripheral
granulocytes and monocytes/macrophages which show activation behavior and prolonged …

Clinical guidance of pyoderma gangrenosum 2022

T Yamamoto, K Yamasaki, K Yamanaka… - The Journal of …, 2023 - Wiley Online Library
Pyoderma gangrenosum (PG) is a rare, neutrophilic skin disease. For the purpose of
accurate diagnosis and proper treatment of PG, the Japanese clinical practice guidance for …

Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier‐based granulocyte …

K Hiraishi, Y Takeda, N Shiobara… - Therapeutic …, 2003 - Wiley Online Library
Granulocyte and monocyte adsorptive apheresis (GMA) using a column filled with cellulose
acetate (CA) beads (carriers) has been associated with a significant clinical efficacy in …

Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study

Y Fukuda, T Matsui, Y Suzuki, K Kanke… - Journal of …, 2004 - Springer
Abstract Background Active Crohn's disease (CD) is often associated with elevated levels of
platelets, granulocytes, and monocytes that are activated and resistant to apoptosis. The …